A Satisfaction Survey of Current Medicines Used for Migraine Therapy in China: Is Chinese Patent Medicine Effective Compared with Western Medicine for the Acute Treatment of Migraine?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Satisfaction Survey of Current Medicines Used for Migraine Therapy in China: Is Chinese Patent Medicine Effective Compared with Western Medicine for the Acute Treatment of Migraine?

Published:2013-11-08 Issue:2 Volume:15 Page:320-328
ISSN:1526-2375
Container-title:Pain Medicine
language:en
Short-container-title:Pain Med

Author:

Luo Ning¹²,Qi Weiwei¹,Zhuang Can²,Di Wei¹,Lu Yonggang²,Huang Zongqing³,Sun Yunguang⁴,Zhang Aiwu¹,Huang Xiaoliang⁵,Tao Yuqian¹,Zhu Yingting⁶,Li Aidong³,Jiang Zhonghua⁴,Massing Mark W.⁷,Fang Yannan¹

Affiliation:

1. Department of Neurology; First Affiliated Hospital of Sun Yat-Sen University; Guangzhou China

2. Affiliated Liuzhou Hospital of Southern Medical University; Guangxi China

3. Affiliated futian hospital of Guangdong medical college; Shenzheng China

4. Liuzhou Hospital of Traditional Chinese Medicine; Guangxi China

5. Pingguo County People's Hospital; Guangxi China

6. Zhongshan Ophthalmic Center; Sun Yat-Sen University; Guangzhou China

7. The Carolinas Center for Medical Excellence; Cary North Carolina USA

Publisher

Oxford University Press (OUP)

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),General Medicine

Link

http://academic.oup.com/painmedicine/article-pdf/15/2/320/5165882/15-2-320.pdf

Reference27 articles.

1. One-year prevalence of migraine in Sweden: A population-based study in adults;Dahlof;Cephalalgia,2001

2. The prevalence and burden of primary headaches in China: A population-based door-to-door survey;Yu;Headache,2012

3. Bending the rule of monotherapy for migraine prevention?;Evans;Headache,2005

4. The use of ligusticum wallichii in different formulas of treating headache;He;Chin J Exp Tradit Med Formulae,2010

5. Dahurian angelica root and Peony power is effective in treating vascular headache: A report of 100 cases;Ma;Henan Tradit Chin Med,2003

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healthcare utilisation and economic burden of migraines among bank employees in China: a probabilistic modelling study;The Journal of Headache and Pain;2024-04-19

2. Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial;The Journal of Headache and Pain;2024-04-16

3. Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial;The Lancet Neurology;2023-06

4. Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China;Pain and Therapy;2023-03-22

5. Safety Findings in Lasmiditan as a Novel Acute Treatment of Migraine in Chinese Patients: A Post Hoc Analysis of the Randomized Controlled Phase 3 CENTURION Trial;Advances in Therapy;2022-09-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3